BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 82,500 | $5,090,000 | 4.20% |
| RTW INVESTMENTS, LP | 122,576 | $7,563,000 | 2.85% |
| Eventide Asset Management | 587,677 | $36,260,000 | 2.36% |
| First Light Asset Management, LLC | 71,246 | $4,396,000 | 1.93% |
| ARK Investment Management | 75,645 | $4,667,000 | 1.70% |
| Taylor Wealth Management Partners | 39,118 | $2,414,000 | 1.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 302,027 | $18,635,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 40,000 | $2,468,000 | 0.58% |
| Artal Group S.A. | 422,536 | $26,070,000 | 0.58% |
| TURNER INVESTMENTS LLC | 21,020 | $1,297,000 | 0.52% |